POC Blood Gas and Electrolyte Market Size was valued at USD 2.8 Billion in 2023. The POC Blood Gas and Electrolyte market Type is projected to grow from USD 3.03 Billion in 2024 to USD 5.4 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.45% during the forecast period (2024 - 2032). Respiratory acidosis and other problems are becoming more and more common, are the key market drivers enhancing the market growth.
Source Secondary Research, Primary Research, MRFR Database and Analyst Review
In July 2022, EDAN Instruments, Inc., announced the official launch of the i20, a POC (Point-of-Care) fluorescence-based CO-OX blood gas and chemistry analysis system. The i20 is equipped with over 45 parameters, including electrolytes, blood gases, and CO-oximetry. The new system is intended to alleviate the burden in specific patient care contexts, including emergency departments, pulmonary units, intensive care units, neonatal intensive care, and operating rooms. The technology and its photoluminescent biosensor significantly enhance the accuracy and stability of the system, while simultaneously eradicating the expenses associated with staff training, space, and maintenance. Numerous emergency-care providers regard the blood gas test as the most critical point-of-care (POC) diagnostic. The newly added analytes (tHb, sO2, FO2Hb, FHHb, FCOHb, FMetHb) on i20 are specifically designed to meet the typical clinical applications of CO-oximetry, such as intoxication or other clinical situations that affect Hb's capacity to transport oxygen. The optimal fit across clinical departments would be the true integration of a blood gas analyzer and a CO-oximetry analyzer, which the i20 has achieved due to its small size. Our foremost concern would consistently be the clinical requirements. For years, their primary concerns have been size, CO-OX, maintenance, operations, and expenditures.
Increases in the prevalence of chronic diseases, the geriatric population, the number of patients being treated in intensive care units, neonatal intensive care units, and emergency departments, technological advancements in blood gas and electrolyte analyzers, and an increase in the number of product approvals ly are the main factors driving the growth of the blood gas and electrolyte analyzers market. Additionally, a substantial possibility for market growth exists with the integration of blood gas analyzers with electronic medical records and laboratory information systems. These integrated technologies not only enable precise patient health monitoring but also facilitate workflow. Additionally, the market for blood gas and electrolyte analyzers is anticipated to be greatly boosted throughout the projected years due to the growth in demand for technology-integrated combination systems and point-of-care devices.
Additionally, the availability of various portable, benchtop, simple to use, accurate, and quick devices, increase in government initiatives and strategies, and key market players playing a crucial role in raising awareness for diagnosis all contribute to the growth of the blood gas and electrolyte analyzers market. A significant increase in healthcare spending around the world has further stimulated the market. The population is growing, especially among the elderly, and more people are using medical services, which are the main causes of the rise in healthcare costs. The development of the blood gas and electrolyte analyzers market, however, is anticipated to be hampered by the high cost of the analyzers and the complexity involved in interpreting blood analysis results.
The region in hospitals where patients are being ventilated is where point-of-care blood gas and electrolyte devices are most frequently employed. The expansion of the point of care blood gas and electrolyte devices market has been aided by a rise in treatments in NICUs, ICUs, CVOR, and emergency departments. In addition, the increased incidence of cancer and chronic disorders drives market expansion. The increasing disease burden and a rapidly expanding geriatric population base in developing countries will have a substantial impact on the market for blood gas and electrolyte analyzers. Furthermore, a number of infectious and chronic diseases are more likely to affect the elderly. For the treatment of many disorders, accurate blood sample analysis in a timely manner is necessary.
The number of patients needing emergency room care has increased dramatically as a result. Due to the rising demand for point-of-care blood gas and electrolyte analyzers as well as the growing popularity of portable devices, the portable analyzer category made for more than 64% of the blood gas and electrolyte analyzers market. These devices deliver speedy results, are practical, affordable, and easy to use. Additionally, they do not demand the involvement of any qualified medical professionals. The key obstacle for this sector is the high cost of replacement and upkeep. Technical developments in blood gas and electrolyte analysis equipment will also enhance the industry during the course of the projection period. The market has a profitable possibility for growth here. Thus, driving the POC Blood Gas and Electrolyte market revenue.
The POC Blood Gas and Electrolyte market segmentation, based on product, includes consumables and instruments. Consumables segment dominated the market in 2022. This is due to an increase in patients with chronic conditions, which leads to a rise in the quantity of blood gas tests conducted. Additionally, this causes the need for consumables to rise.
The POC Blood Gas and Electrolyte market segmentation, based on end user, includes hospitals & clinics and research institutions. Hospitals and clinics segment dominated the POC Blood Gas and Electrolyte market in 2022. This is due to an increase in hospitalisations of patients, as hospitals treat the majority of critically ill patients.
Figure 1 POC Blood Gas and Electrolyte Market, by End User, 2023 & 2032 (USD Billion)
Source Secondary Research, Primary Research, MRFR Database and Analyst Review
By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North America POC Blood Gas and Electrolyte Market dominated this market in 2022 (45.80%). This is due to the fact that chronic diseases like diabetes, kidney disease, and liver disease are quite common as well as the fact that the government now funds more research and development. Furthermore, the market for point-of-care blood gas and electrolyte analysis in this field is dominated by a small number of significant players. According to the Centres for Disease Control and Prevention (CDC), 30.3 million Americans of all ages were diagnosed with diabetes in 2015. The number of diabetic patients is rising, which boosts hospital traffic and fuels a significant need for POC blood gas and electrolyte equipment. Further, the U.S. POC Blood Gas and Electrolyte market held the largest market share, and the Canada POC Blood Gas and Electrolyte market was the fastest growing market in the North America region.
Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 2 POC BLOOD GAS AND ELECTROLYTE MARKET SHARE BY REGION 2023 (USD Billion)
Source Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe POC Blood Gas and Electrolyte market accounted for the healthy market share in 2022. This is due to both the rising prevalence of chronic diseases including diabetes, renal disease, and liver disease and the increasing funding for research and development by governments worldwide. There are also only a few of major players in the point-of-care blood gas and electrolyte analysis market. In 2015, it was estimated by the Centres for Disease Control and Prevention (CDC) that 30.3% of all Americans were living with diabetes. As the prevalence of diabetes rises, so does the need for point-of-care (POC) blood gas and electrolyte monitoring systems in hospitals. Further, the German POC Blood Gas and Electrolyte market held the largest market share, and the U.K POC Blood Gas and Electrolyte market was the fastest growing market in the European region
The Asia Pacific POC Blood Gas and Electrolyte market is expected to register significant growth from 2023 to 2032. The population of obese and diabetic people is growing quickly, and healthcare costs are going up. 60% of the world's diabetic population, according to the WHO, is in the Asia Pacific region. Furthermore, the presence of quickly growing economies like China and India is projected to support market expansion throughout the projection period. Moreover, China’s POC Blood Gas and Electrolyte market held the largest market share, and the Indian POC Blood Gas and Electrolyte market was the fastest growing market in the Asia-Pacific region.
POC Blood Gas and Electrolyte Key Market Players & Competitive Insights
Leading market players are investing heavily in research and development in order to expand their product lines, which will help the POC Blood Gas and Electrolyte market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, POC Blood Gas and Electrolyte Industry must offer cost-effective items.
Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the POC Blood Gas and Electrolyte Industry to benefit clients and increase the market sector. In recent years, the POC Blood Gas and Electrolyte Industry has offered some of the most significant advantages to medicine. Major players in the POC Blood Gas and Electrolyte market, including Siemens, Abbott, F. Hoffman-La Roche Ltd., Radiometer, Nova medical, Edan Instruments Inc., and Instrumentation Laboratory, are attempting to increase market demand by investing in research and development operations.
Medical equipment distributor Sysmex Corp (Sysmex). It conducts research, develops, produces, and markets equipment, reagents, and software programmes that simplify medical examinations, treatment, and illness management. The business provides clinical laboratories with diagnostic tools, reagents, and lab information systems for testing. The company provides urinalysis analyzers, haemostasis, and haematology products. At its locations in Japan, New Zealand, France, Germany, and the US, it carries out research and development. Together with its subsidiaries, the corporation conducts business across the Americas, Europe, the Middle East, Africa, and Asia-Pacific. Institutions that practise medicine use its products. The headquarters of Sysmex are in Hyogo, Japan. A well-known brand in the diagnostics solutions sector, Sysmex America Inc., gained FDA approval in June 2022 for the inclusion of a new function to its N-10 Automated Haematology Analyzer with Blood Bank mode. The first automated analyzer approved for residual WBC counting is this one.
A division of Siemens AG, Siemens Healthineers AG (Siemens Healthineers) is a manufacturer and distributor of diagnostic imaging systems, clinical and workflow systems and solutions, and systems for minimally invasive treatments. The company's key products include mobile C-arms, hybrid operating rooms, angiography systems, ultrasound systems, computed tomography systems, magnetic resonance imaging systems, testing systems, and point-of-care (POC) testing systems. Additionally, it provides business and digital services. Physicians, public health organisations, universities, state-run and private health insurance, pharmaceutical firms, and clinical research institutions are among the healthcare providers served by Siemens Healthineers. The corporation has operations in Asia-Pacific, Europe, the Americas, the Middle East, and Africa. Erlangen, Germany serves as the home base for Siemens Healthineers. The epoc Blood Analysis System was introduced by Siemens Healthineers in April 2021. It is a portable, wireless system that provides patient-side results in under a minute and includes complete blood gas, a basic metabolic panel, hematocrit, and lactate on a single room temperature-stable test card. It helps to support Covid-19 response initiatives, where blood gas analysis is crucial for treating infected individuals.
Key Companies in the POC Blood Gas and Electrolyte market include
POC Blood Gas and Electrolyte Industry Developments
January 2021 Envea unveiled the MIR 9000P, a revolutionary portable multi-gas monitor created to specifically address regulatory and periodic requirements. The most recent European standard for portable automatic measurement systems, EN 15267-4, and United States Environmental Protection Agency are two worldwide directives and standards that MIR 9000P complies with.
March 2020 The United States Food and Drug Administration has approved the use of the Siemens Healthineers RAPIDPoint 500e Blood Gas Analyzer in critical care settings.
| Report Attribute/Metric | Details |
| Market Size 2023 | USD 2.8 Billion |
| Market Size 2024 | USD 3.03 Billion |
| Market Size 2032 | USD 5.4 Billion |
| Compound Annual Growth Rate (CAGR) | 7.45% (2024-2032) |
| Base Year | 2023 |
| Market Forecast Period | 2024-2032 |
| Historical Data | 2018- 2022 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Product, End User, and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and the Rest of the World |
| Countries Covered | The U.S., Canada, German, France, U.K, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled | Siemens, Abbott, F. Hoffman-La Roche Ltd., Radiometer, Nova medical, Edan Instruments Inc., and Instrumentation Laboratory |
| Key Market Opportunities | New product launches and R&D among key players |
| Key Market Dynamics | Increasing prevalence of respiratory acidosis and increasing prevalence of various disorders |
POC Blood Gas and Electrolyte Market Highlights:
Frequently Asked Questions (FAQ) :
The POC Blood Gas and Electrolyte market size was valued at USD 2.8 Billion in 2023.
The market is projected to grow at a CAGR of 7.45% during the forecast period, 2024-2032.
North America had the largest share in the market
The key players in the market are Siemens, Abbott, F. Hoffman-La Roche Ltd., Radiometer, Nova medical, Edan Instruments Inc., and Instrumentation Laboratory
The Consumables Product dominated the market in 2022.
The Hospitals & Clinics End User had the largest share in the market.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Research Analyst Level I He is an extremely curious individual currently working in healthcare and medical devices domain. kinjoll is comfortably versed in data centric research backed by healthcare educational background. he leverages extensive data mining and analytics tools such as primary and secondary research, statistical analysis, machine learning, data modelling. his key role also involves technical sales support, client interaction and project management within the healthcare team. lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
